Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Biomerica Inc.

    NASDAQ: BMRA · Real-Time Price · USD
    3.11
    -0.09 (-2.81%)
    At close: Jun 27, 2025, 3:58 PM
    3.15
    1.29%
    After-hours: Jun 27, 2025, 04:04 PM EDT

    Biomerica Statistics

    Share Statistics

    Biomerica has 2.55M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 2.55M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 8.21%

    Shares Floating

    n/a
    		 2.3M

    Failed to Deliver (FTD) Shares

    n/a
    		 575

    FTD / Avg. Volume

    n/a
    		 1.73%

    Short Selling Information

    The latest short interest is 47.86K, so 1.88% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 47.86K

    Short % of Shares Out

    n/a
    		 1.88%

    Short % of Float

    n/a
    		 2%

    Short Ratio (days to cover)

    n/a
    		 1.65

    Valuation Ratios

    The PE ratio is -13.06 and the forward PE ratio is null. Biomerica's PEG ratio is 0.47.

    PE Ratio

    n/a
    		 -13.06

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 14.41

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 11.84

    P/FCF Ratio

    n/a
    		 -14.25

    PEG Ratio

    n/a
    		 0.47
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Biomerica.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.12.

    Current Ratio

    n/a
    		 3.51

    Quick Ratio

    n/a
    		 2.43

    Debt / Equity

    n/a
    		 0.12

    Debt / EBITDA

    n/a
    		 -0.13

    Debt / FCF

    n/a
    		 -0.14

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $84,609.38

    Profits Per Employee

    n/a
    		 $-93,406.25

    Employee Count

    n/a
    		 64

    Asset Turnover

    n/a
    		 0.59

    Inventory Turnover

    n/a
    		 2.02

    Taxes

    Income Tax

    n/a
    		 42K

    Effective Tax Rate

    n/a
    		 -0.71%

    Stock Price Statistics

    The stock price has increased by -15.56% in the last 52 weeks. The beta is 0.33, so Biomerica's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.33

    52-Week Price Change

    n/a
    		 -15.56%

    50-Day Moving Average

    n/a
    		 3.44

    200-Day Moving Average

    n/a
    		 3.6

    Relative Strength Index (RSI)

    n/a
    		 45.38

    Average Volume (20 Days)

    n/a
    		 33,208

    Income Statement

    In the last 12 months, Biomerica had revenue of 5.42M and earned -5.98M in profits. Earnings per share was -0.36.

    Revenue

    n/a
    		 5.42M

    Gross Profit

    n/a
    		 611K

    Operating Income

    n/a
    		 -6.37M

    Net Income

    n/a
    		 -5.98M

    EBITDA

    n/a
    		 -5.99M

    EBIT

    n/a
    		 -6.37M

    Earnings Per Share (EPS)

    n/a
    		 -0.36
    Full Income Statement

    Balance Sheet

    The company has 4.17M in cash and 785K in debt, giving a net cash position of 3.38M.

    Cash & Cash Equivalents

    n/a
    		 4.17M

    Total Debt

    n/a
    		 785K

    Net Cash

    n/a
    		 3.38M

    Retained Earnings

    n/a
    		 -48.2M

    Total Assets

    n/a
    		 7.38M

    Working Capital

    n/a
    		 4.55M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -5.36M and capital expenditures -115K, giving a free cash flow of -5.48M.

    Operating Cash Flow

    n/a
    		 -5.36M

    Capital Expenditures

    n/a
    		 -115K

    Free Cash Flow

    n/a
    		 -5.48M

    FCF Per Share

    n/a
    		 -0.33
    Full Cash Flow Statement

    Margins

    Gross margin is 11.28%, with operating and profit margins of -117.58% and -110.4%.

    Gross Margin

    n/a
    		 11.28%

    Operating Margin

    n/a
    		 -117.58%

    Pretax Margin

    n/a
    		 -109.62%

    Profit Margin

    n/a
    		 -110.4%

    EBITDA Margin

    n/a
    		 -110.67%

    EBIT Margin

    n/a
    		 -117.58%

    FCF Margin

    n/a
    		 -101.13%

    Dividends & Yields

    BMRA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BMRA.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 21, 2025. It was a backward split with a ratio of 1:8.

    Last Split Date

    n/a
    		 Apr 21, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:8

    Scores

    Altman Z-Score

    n/a
    		 -7.93

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist